Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 139 record(s)

Req # A-2021-000843

Adverse Drug Reaction (ADR) for TRAZODONE HYDROCHLORIDE. Report number: E2B_03454054.

Organization: Health Canada

21 page(s)
November 2021

Req # A-2021-000847

Adverse Drug Reactions (ADRs) for RAMIPRIL: Report numbers: 000944114, 000945315, 000944049.

Organization: Health Canada

54 page(s)
November 2021

Req # A-2021-000864

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE: Report numbers: E2B_03496094, E2B_03496647, E2B_03349834, E2B_03502557, E2B_03498845.

Organization: Health Canada

269 page(s)
November 2021

Req # A-2021-000868

Adverse Drug Reaction (ADR) for ACETYLSALICYLIC ACID: Report number: E2B_03502967.

Organization: Health Canada

14 page(s)
November 2021

Req # A-2021-000876

Adverse Drug Reactions (ADRs). Report numbers: E2B_01709298, E2B_02155051, E2B_01874534, E2B_01818855, E2B_02313523, E2B_01839026, E2B_02030427, E2B_02034411, E2B_02032772, E2B_02053947, E2B_02056993, E2B_02073783, E2B_02147270, E2B_02158798,…

Organization: Health Canada

368 page(s)
November 2021

Req # A-2021-000886

Adverse Drug Reaction (ADR) for Hizentra. Report number: E2B_03743938.

Organization: Health Canada

18 page(s)
November 2021

Req # A-2021-000891

Adverse Drug Reaction (ADR). Report number: 000951564.

Organization: Health Canada

2 page(s)
November 2021

Req # A-2021-000908

Adverse Drug Reaction (ADR) for DAUNORUBICIN. Report number: E2B_03971763.

Organization: Health Canada

20 page(s)
November 2021

Req # A-2021-000911

Adverse Drug Reactions (ADRs) for Diclectin (doxylamine succinate / pyridoxine hydrochloride). Report numbers: 000953406, 000953437.

Organization: Health Canada

6 page(s)
November 2021

Req # A-2021-000948

Adverse Drug Reactions (ADRs) for Eligard. Report numbers: E2B_03828775, E2B_03828761, E2B_03828756.

Organization: Health Canada

29 page(s)
November 2021
Date modified: